Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Christine E. Oborski"'
Autor:
Timothy A. Subashi, Douglas S. Johnson, Christine E. Oborski, Kevin Atchison, Kathleen M. Wood, Christine P. Parker, Rathna Iyer, Bruce A. Maguire, Martin Pettersson, Kelly R. Bales, Nikolay Pozdnyakov, Gary Bora
Publikováno v:
Neuroscience and Medicine. :149-161
γ-Secretase is involved in the final processing of the amyloid precursor protein into a heterogeneous pool of β-amyloid (Aβ) peptides. Current Alzheimer’s disease drug discovery efforts include targeting γ-secretase activity in brain to attenua
Autor:
Douglas E. Wood, Robert B. Nelson, Barbara G. Sahagan, Xingrong Liu, Lei Zhang, Nikolay Pozdnyakov, Jeffrey Van Deusen, Karl E.G. Richter, James E. Finley, Christine P. Parker, Karen J. Coffman, Michael Aaron Brodney, Barbara-Anne Martin, David D. Auperin, Joel B. Schachter, Dane R. Liston, Michael J. Karmilowicz, Tracy M. Brown, Barbara Tate, Christine E. Oborski, Sharon A. Sokolowski, Stacey L. Becker, Bronk Brian Scott, Thomas A. Lanz, Carol D. Hicks, Charles E. Nolan, Kathleen M. Wood
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:2637-2640
A novel series of tetralin containing amino imidazoles, derived from modification of the corresponding phenyl acetic acid derivatives is described. Replacement of the amide led to identification of a potent series of tetralin-amino imidazoles with ro
Autor:
Kathleen M. Wood, Ping Du, Karen J. Coffman, Karl E.G. Richter, Sharon A. Sokolowski, Barbara-Anne Martin, Dane R. Liston, Barbara Tate, Douglas E. Wood, Tracy M. Brown, Michael Aaron Brodney, Carol D. Hicks, Charles E. Nolan, Nikolay Pozdnyakov, James E. Finley, Christine E. Oborski, Stacey L. Becker, Thomas A. Lanz, Kieran F. Geoghegan
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 334:269-277
PF-3084014 [(S)-2-((S)-5,7-difluoro-1,2,3,4-tetrahydronaphthalen-3-ylamino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide] is a novel gamma-secretase inhibitor that reduces amyloid-beta (Abeta) production with an in vitro
Autor:
Claude Ambroise, Matthew F. Calabrese, David Riddell, Stephen Noell, Christine E. Oborski, Warren D. Hirst, Zdenek Berger, Sarah Perkins
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 3, p e0119141 (2015)
PLoS ONE, Vol 10, Iss 3, p e0119141 (2015)
Mutations in glucocerebrosidase (GBA1) cause Gaucher disease and also represent a common risk factor for Parkinson’s disease and Dementia with Lewy bodies. Recently, new tool molecules were described which can increase turnover of an artificial sub
Autor:
Yasong Lu, Liming Zhang, David Riddell, Cathleen Gonzales, Antonia F. Stepan, Michael Aaron Brodney, Stephen Noell, Leslie R. Pustilnik, Charles E. Nolan, Eva Hajos-Korcsok, Christine E. Oborski, Kevin Atchison, Ivan Viktorovich Efremov, Claude Ambroise, Ashley Robshaw, Chakrapani Subramanyam
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
Michael Aaron Brodney, Kevin Atchison, Yao Zhang, Cheng Chang, Leslie R. Pustilnik, Yasong Lu, Sandra J. Engle, Stephen Noell, Kewa Mou, Ashley Robshaw, David Riddell, Charles E. Nolan, Christine E. Oborski
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
Andre Negahban, Kevin Atchison, Stephen Noell, Cathleen Gonzales, David Riddell, Leslie R. Pustilnik, Christopher Ryan Butler, Brian T. O’Neill, Cheng Chang, Shawn D. Doran, Feng Pan, Yasong Lu, Elizabeth Mary Beck, Jianhua Liu, Ashley Robshaw, Charles E. Nolan, Christine E. Oborski, Michael Aaron Brodney, Claude Ambroise, Eva Hajos-Korcsok
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
ONeill Brian, Claude Ambroise, Michael Aaron Brodney, Christine E. Oborski, Kevin Atchison, David Riddell, Stephen Noell, Charles E. Nolan, Leslie R. Pustilnik
Publikováno v:
Alzheimer's & Dementia. 9
Autor:
Jane M. Withka, Ivan Viktorovich Efremov, Jianhua Liu, Alison H. Varghese, Felix Vajdos, Kevin Ogilvie, Kris A. Borzilleri, Michael Aaron Brodney, Claude Ambroise, Gabriela Barreiro, Eva Hajos-Korcsok, Lorraine F. Lanyon, Curt Christoffersen, Christine E. Oborski, Katherine Fisher, Charles E. Nolan, John C. Murray, Brian T. O’Neill
Publikováno v:
Journal of medicinal chemistry. 55(21)
β-Secretase 1 (BACE-1) is an attractive therapeutic target for the treatment and prevention of Alzheimer's disease (AD). Herein, we describe the discovery of a novel class of BACE-1 inhibitors represented by sulfamide 14g, using a medicinal chemistr
Autor:
Jason K. Dutra, Jayvardhan Pandit, Hong Wang, Mahmoud N. Mansour, Christine E. Oborski, Binqing Wei, Alexander S. McColl, Theresa J. O’Sullivan, Steven W. Goldstein, Steven Capetta, Stephen Noell, Jane M. Withka, Dorff Peter H, Hou Chen, Thomas N. O'Connell, Felix Vajdos, Ivan Viktorovich Efremov, Kris A. Borzilleri
Publikováno v:
Journal of medicinal chemistry. 55(21)
The aspartyl protease β-secretase, or BACE, has been demonstrated to be a key factor in the proteolytic formation of Aβ-peptide, a major component of plaques in the brains of Alzheimer’s disease (AD) patients, and inhibition of this enzyme has em